HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate-Palmolive

This article was originally published in The Rose Sheet

Executive Summary

Colgate marketer has completed its purchase of 84% of natural toothpaste company Tom's of Maine for approximately $100 mil., firm reports May 1. Completion of sale allows company to "move forward on this opportunity to enter the fast-growing naturals category," company notes. The purchase agreement was announced and signed in March, making Colgate the only global oral care firm that serves the health and specialty trade channel (1"The Rose Sheet" March 27, 2006, p. 3)...

You may also be interested in...



Colgate Reaps Benefit Of Marketing Dollars Sown, Remains Market Leader

Marketing initiatives to support a steady chain of new products - including Colgate Total Advanced Clean and Max Fresh First toothpastes - paid off during the first quarter of fiscal year 2007, increasing sales by double digits, according to Colgate-Palmolive

Wave, Colgate Primed For Natural Products Wave, Touts Mexican, Russian Markets

Colgate-Palmolive expects to ride a "wave" of growth in natural oral care products through its majority-owned subsidiary Tom's of Maine

Colgate Snaps Up Tom’s Of Maine In $100 Mil. Deal

Colgate-Palmolive's planned acquisition of natural toothpaste marketer Tom's of Maine will establish the company as the only global oral care firm that serves the health and specialty trade channel, Colgate announced March 21

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel